CVM

Cel Sci (CVM)

Cel Sci Corporation New

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:AMEX:CVM

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/16	20:30	Business Wire	CEL-SCI’s Multikine® Increased 5-Year Survival Rate to 82.6% in Locally Advanced Resectable Head & Neck Cancer Patients Who Were Deemed to be in the Treatment Group for Surgery and Radiation	AMEX:CVM	Cel Sci Corporation New
2024/09/10	22:32	Business Wire	CEL-SCI to Present New Data for Multikine® Head & Neck Cancer Immunotherapy at the European Society for Medical Oncology 2024 Congress	AMEX:CVM	Cel Sci Corporation New
2024/09/04	22:00	Business Wire	The UK’s Medicines & Healthcare Products Regulatory Agency Grants CEL-SCI a Pediatric Waiver, Bringing Multikine® One Step Closer to Future Marketing Clearance	AMEX:CVM	Cel Sci Corporation New
2024/08/31	05:32	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	AMEX:CVM	Cel Sci Corporation New
2024/08/15	21:00	Business Wire	CEL-SCI Corporation Reports Third Quarter Fiscal 2024 Financial Results	AMEX:CVM	Cel Sci Corporation New
2024/08/15	05:27	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:CVM	Cel Sci Corporation New
2024/07/30	06:16	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:CVM	Cel Sci Corporation New
2024/07/30	05:05	Business Wire	CEL-SCI Announces Closing of $10.8 Million Offering	AMEX:CVM	Cel Sci Corporation New
2024/07/29	20:00	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	AMEX:CVM	Cel Sci Corporation New
2024/07/27	06:27	Edgar (US Regulatory)	Form 8-K - Current report	AMEX:CVM	Cel Sci Corporation New
2024/07/27	00:52	Business Wire	CEL-SCI Announces Pricing of $10.8 Million Offering	AMEX:CVM	Cel Sci Corporation New
2024/07/26	21:23	Business Wire	CEL-SCI’s Phase 3 Population Analysis for Upcoming Confirmatory Registration Study in Head & Neck Cancer Demonstrates Well Balanced Patient Population, Confidence in Clinical Results	AMEX:CVM	Cel Sci Corporation New
2024/07/08	22:15	Business Wire	CEL-SCI Appoints Robert Watson as Chairperson of the Board	AMEX:CVM	Cel Sci Corporation New
2024/06/18	21:00	Business Wire	CEL-SCI Presents Head & Neck Cancer Data at Iddst Annual Congress in Budapest: Risk of Death Cut in Half for Patients Treated With Multikine in the Target Population	AMEX:CVM	Cel Sci Corporation New
2024/06/06	20:00	Business Wire	Dr. Giovanni Selvaggi, Who Has Brought Several Oncology Drugs to Market, Joins CEL-SCI as Clinical Advisor	AMEX:CVM	Cel Sci Corporation New
2024/05/16	22:00	Business Wire	CEL-SCI Corporation Reports Second Quarter Fiscal 2024 Financial Results	AMEX:CVM	Cel Sci Corporation New
2024/05/16	05:17	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:CVM	Cel Sci Corporation New
2024/05/10	22:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:CVM	Cel Sci Corporation New
2024/05/10	02:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:CVM	Cel Sci Corporation New
2024/05/09	22:19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	AMEX:CVM	Cel Sci Corporation New
2024/05/08	22:00	Business Wire	CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer	AMEX:CVM	Cel Sci Corporation New
2024/04/23	22:00	Business Wire	CEL-SCI Appoints Mario Gobbo to Its Board of Directors	AMEX:CVM	Cel Sci Corporation New
2024/03/19	22:00	Business Wire	CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology	AMEX:CVM	Cel Sci Corporation New
2024/03/08	01:33	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	AMEX:CVM	Cel Sci Corporation New
2024/03/08	01:33	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	AMEX:CVM	Cel Sci Corporation New
2024/03/08	01:31	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	AMEX:CVM	Cel Sci Corporation New
2024/03/06	22:45	Business Wire	CEL-SCI Corporation Issues Letter to Shareholders	AMEX:CVM	Cel Sci Corporation New
2024/02/15	22:00	Business Wire	CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results	AMEX:CVM	Cel Sci Corporation New
2024/02/15	06:31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	AMEX:CVM	Cel Sci Corporation New
2024/02/14	02:00	Business Wire	CEL-SCI Announces Closing of $7.75 Million Public Offering of Common Stock	AMEX:CVM	Cel Sci Corporation New